You are invited to a national accredited medical education program designed to support healthcare
professionals involved in the administration of subcutaneous immunotherapy in lung cancer.

Upon completion of this program, participants will be able to:

• Compare the efficacy and safety of subcutaneous vs. intravenous immuno-oncology (IO) therapies for non-small cell lung cancer (NSCLC).
• Implement appropriate monitoring and safety protocols, including adverse event recognition and management, for patients receiving subcutaneous IO therapy.
• Demonstrate proper administration technique for subcutaneous IO therapies and troubleshoot real-world clinical scenarios.

This program is accredited by the Canadian Nurses Association.